felin
coronaviru
fcov
envelop
positivestrand
rna
viru
belong
famili
coronavirida
subfamili
coronavirina
genu
alphacoronaviru
two
serotyp
fcov
fcov
classifi
type
ii
base
amino
acid
sequenc
spike
protein
separ
serotyp
fcov
classifi
two
biotyp
weakli
pathogen
felin
enter
coronaviru
fecv
avirul
fcov
strongli
pathogen
felin
infecti
periton
viru
fipv
virul
fcov
fip
lethal
immunemedi
infecti
diseas
member
famili
felida
establish
therapi
treatment
suggest
fipv
mutant
fecv
ie
consid
infect
cat
open
read
frame
orf
gene
gene
fecv
partial
mutat
cat
bodi
becom
virul
fcov
fipv
presenc
fcov
broad
pathogen
spectrum
field
also
propos
anoth
hypothesi
serotyp
ii
fecv
fipv
fcov
serotyp
ii
fcov
known
util
felin
aminopeptidas
n
fapn
viru
receptor
orf
fcov
genom
encod
structur
protein
protein
encod
play
essenti
role
cell
entri
involv
bind
fcovspecif
receptor
host
cell
surfac
fusion
cell
membran
protein
also
play
import
role
antibodydepend
enhanc
ade
fipv
infect
ade
phenomenon
bind
antibodi
make
host
cell
entri
easier
viru
previous
report
monoclon
antibodi
mab
protein
mediat
ade
fipv
infect
ade
fipv
infect
occur
viru
product
macrophag
increas
product
inflammatori
cytokin
tumor
necrosi
factor
alpha
interleukin
il
enhanc
therefor
ade
close
associ
sever
fipv
infect
howev
studi
differ
pathogen
fipv
fecv
regard
ade
infect
report
sinc
serotyp
fcov
infect
domin
field
desir
use
serotyp
fcov
studi
fip
howev
isol
serotyp
fecv
use
cultur
cell
line
success
difficult
studi
ade
infect
vitro
moreov
mab
induc
ade
activ
serotyp
fcov
yet
prepar
studi
use
laboratori
strain
serotyp
ii
fipv
wsu
fipv
serotyp
ii
fecv
wsu
fecv
investig
relationship
ade
induct
inflammatori
cytokin
pathogenesisrel
factor
strain
feli
catu
whole
fetu
fcwf
cell
kindli
suppli
dr
c
horzinek
state
univers
utrecht
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
u
penicillin
per
ml
streptomycin
per
ml
cell
human
monocyt
cell
line
cultur
rpmi
medium
contain
fc
antibiot
primari
felin
monocyt
maintain
rpmi
growth
medium
supplement
fc
u
penicillin
per
ml
streptomycin
per
ml
fipv
kindli
provid
dr
c
horzinek
fecv
kindli
suppli
dr
j
mckeirnan
washington
state
univers
virus
grown
cell
mab
use
present
studi
recogn
protein
serotyp
ii
fcov
report
mab
exhibit
neutral
activ
crfk
cell
enhanc
activ
primari
felin
monocyt
macrophag
depend
reaction
condit
mab
use
dilut
except
experi
shown
fig
mab
recogn
fapn
mab
control
recogn
felin
interferongamma
prepar
laboratori
use
fipv
fecv
react
mab
h
ad
cultur
adsorb
cell
cell
tube
h
cell
wash
three
time
pb
cultur
tube
h
supernat
collect
viru
titer
cultur
supernat
determin
method
reed
muench
cell
primari
felin
monocyt
isol
specificpathogenfre
spf
cat
describ
previous
dewerchin
et
al
blood
sampl
spf
cat
perform
accord
guidelin
anim
experi
kitasato
univers
approv
number
fipv
fecv
react
mab
h
ad
cultur
adsorb
primari
felin
monocyt
cell
multipl
h
cell
wash
three
time
pb
cultur
multipl
h
supernat
cell
collect
viru
titer
cultur
supernat
determin
method
reed
muench
cell
cell
use
measur
mrna
express
level
inflammatori
cytokin
primari
felin
monocyt
cell
cultur
medium
contain
mab
mab
control
multipl
hour
wash
pb
fipv
fecv
x
without
pretreat
mab
ad
cultur
allow
adsorb
cell
h
presenc
mab
wash
pb
cell
cultur
medium
cultur
supernat
collect
h
viru
titer
cultur
supernat
determin
method
reed
muench
cell
primari
felin
monocyt
cell
cultur
medium
contain
chloroquin
wako
pure
chemic
industri
japan
ammonium
chlorid
wako
pure
chemic
industri
japan
multipl
h
wash
pb
fipv
fecv
without
pretreat
mab
ad
cultur
allow
adsorb
cell
h
presenc
chloroquin
ammonium
chlorid
wash
pb
cell
cultur
medium
contain
chloroquin
ammonium
chlorid
cultur
supernat
collect
h
viru
titer
cultur
supernat
determin
method
reed
muench
cell
evalu
cytotox
effect
chloroquin
ammonium
chlorid
primari
felin
monocyt
cell
viabil
measur
assay
describ
rna
isol
cdna
prepar
perform
employ
method
takano
et
al
cdna
amplifi
pcr
use
specif
primer
felin
glyceraldehyd
dehydrogenas
gapdh
mrna
mrna
mrna
mrna
primer
sequenc
shown
tabl
pcr
perform
use
method
takano
et
al
band
densiti
quantifi
appropri
uv
exposur
video
densitometri
use
imag
j
softwar
nih
usa
mrna
mrna
mrna
semiquantit
analyz
term
rel
densiti
valu
mrna
housekeep
gene
gapdh
data
two
group
analyz
student
ttest
multipl
group
analyz
oneway
anova
cell
express
fapn
fipv
alon
infect
cell
enter
fipv
via
cellsurfac
fc
receptor
antifcov
antibodi
present
therefor
cell
use
predict
model
determin
mab
concentr
requir
ade
fecv
infect
vitro
fig
fcov
infect
cell
absenc
mab
sever
dilut
mab
incub
viru
titer
fipv
increas
cultur
supernat
sever
dilut
mab
contrast
fipv
titer
fecv
increas
dilut
except
ie
maximum
ade
activ
fecv
infect
occur
mab
dilut
investig
ade
activ
fecv
infect
primari
felin
monocyt
fig
mab
dilut
enhanc
infect
monocyt
fipv
median
increas
infect
viru
alon
viru
alon
viru
mab
hand
mab
dilut
slightli
increas
infect
cell
fecv
median
increas
tenfold
viru
alon
viru
mab
ie
ade
activ
fecv
lower
fipv
involv
viru
receptor
fapn
ade
fecv
infect
primari
felin
monocyt
investig
fig
monocyt
allow
react
mab
beforehand
inocul
fecv
alon
viru
titer
decreas
significantli
viru
alon
viru
mab
howev
monocyt
allow
react
mab
beforehand
inocul
mixtur
fecv
mab
viru
titer
decreas
cell
without
mab
treatment
viru
mab
viru
mab
mab
nearli
ident
result
obtain
case
fipv
fig
ade
activ
fipv
inhibit
action
chloroquin
ammonium
chlorid
endosom
ph
rise
inhibit
fusion
fipv
endosom
membran
cell
treat
chloroquin
ammonium
chlorid
inhibit
fecv
replic
treatment
chloroquin
ammonium
chlorid
report
howev
influenc
chloroquin
ammonium
chlorid
ade
activ
fecv
report
thu
investig
whether
ade
activ
fecv
inhibit
chloroquin
ammonium
chlorid
primari
felin
monocyt
treat
chloroquin
ammonium
chlorid
influenc
viral
replic
fecv
infect
investig
viabil
primari
felin
monocyt
treatment
chloroquin
ammonium
chlorid
mean
sd
mean
sd
respect
viru
titer
significantli
higher
cultur
supernat
monocyt
inocul
mixtur
fecv
mab
monocyt
cultur
viru
alon
viru
alon
viru
mab
howev
treatment
chloroquin
mm
ammonium
chlorid
significantli
decreas
viru
titer
cultur
supernat
cell
infect
viru
alon
mixtur
viru
mab
case
treatment
lysosomotrop
agent
similar
result
obtain
fipv
fig
inflammatori
cytokin
product
enhanc
primari
felin
monocyt
inocul
fipv
presenc
antifipv
antibodi
howev
clear
whether
inflammatori
cytokin
product
increas
ade
fecv
infect
thu
investig
inflammatori
cytokin
mrna
level
primari
felin
monocyt
inocul
mixtur
fecv
mab
fig
mrna
level
significantli
increas
monocyt
inocul
mixtur
fipv
mab
howev
mrna
level
increas
monocyt
inocul
mixtur
fecv
mab
fecv
infect
primari
felin
monocyt
macrophag
infect
fecv
cell
lower
fipv
differ
suggest
correl
pathogen
virus
fecv
assum
caus
almost
clinic
symptom
readili
infect
primari
felin
monocyt
macrophag
replic
local
region
intestin
epithelium
contrast
fipv
consid
caus
fip
readili
infect
primari
felin
monocyt
macrophag
circul
throughout
bodi
howev
conserv
fcov
gene
also
detect
region
intestin
case
fecv
infect
reason
yet
elucid
monocyt
macrophag
infect
fipv
potenti
presenc
antibodi
assum
effici
infect
monocyt
macrophag
fecv
increas
presenc
antibodi
observ
fipv
assumpt
correct
mechan
system
circul
enterocytetrop
fecv
may
explain
thu
investig
whether
fecv
ade
activ
human
histiocyt
lymphoma
cell
line
use
measur
ade
fipv
infect
cell
express
fapn
fipv
alon
infect
cell
enter
cell
via
cellsurfac
fc
receptor
antifcov
antibodi
present
furthermor
felin
monocytemacrophag
cell
line
establish
cell
use
model
predict
ade
activ
fcov
studi
fecv
exhibit
ade
activ
cell
activ
level
lower
fipv
fipv
exhibit
ade
activ
presenc
mab
sever
concentr
fecv
activ
tenfold
dilut
mab
ie
monocyt
infect
effici
fipv
enhanc
presenc
antibodi
increas
effici
fecv
infect
presenc
antibodi
slight
also
investig
differ
ade
activ
fipv
fecv
primari
felin
monocyt
experi
perform
antibodi
concentr
maxim
ade
activ
fecv
base
experiment
result
cell
ade
activ
primari
felin
monocyt
confirm
fipv
fecv
similar
result
experi
cell
ade
activ
level
fecv
lower
fipv
specif
mean
ade
activ
level
fecv
approxim
fipv
fipvinfect
primari
felin
monocyt
macrophag
express
ade
releas
excess
cytokin
viru
product
increas
cytokin
caus
reduct
number
lymphocyt
neutrophil
activ
aggrav
fip
patholog
therefor
highlevel
ade
activ
relat
clinic
aggrav
seriou
state
fipvinfect
cat
therefor
low
ade
activ
fecv
may
reflect
weak
pathogen
fecv
primari
felin
monocyt
ade
activ
level
fecv
lower
fipv
fipv
requir
viru
receptor
enter
cell
induc
ade
fecv
assum
requir
fc
viru
receptor
therefor
fecv
enter
cell
ineffici
mechan
ade
compar
fipv
demonstr
necess
fapn
ade
activ
fecv
investig
whether
antifapn
mab
inhibit
ade
activ
fecv
primari
felin
monocyt
contrari
assumpt
confirm
fecv
like
fipv
use
fapn
ade
suggest
differ
replic
ade
fipv
fecv
occur
enter
cell
nonfapnmedi
cell
entri
mechan
ade
type
ii
fcov
infect
unclear
report
sever
virus
util
viru
receptor
enter
cell
use
antibodi
mechan
elucid
report
virus
possess
envelop
fcov
fuse
envelop
cell
membran
without
mediat
viru
receptor
depend
condit
nonfapnmedi
cell
entri
mechan
type
ii
fcov
investig
necessari
regan
et
al
report
studi
cell
entri
mechan
fecv
entri
depend
endosom
ph
howev
cell
entri
mechan
fecv
ade
clarifi
investig
depend
ph
chloroquin
ammoniumchloridetr
primari
felin
monocyt
fecv
replic
strongli
inhibit
regardless
presenc
absenc
mab
suggest
cell
entri
fecv
depend
endosom
ph
regardless
presenc
absenc
ade
ade
associ
sever
fipv
infect
strong
associ
clinic
symptom
fip
inflammatori
cytokin
level
releas
primari
felin
monocyt
macrophag
ade
mrna
level
significantli
increas
ade
fipv
infect
wherea
increas
note
despit
ade
fecv
infect
observ
sever
studi
relationship
amount
inflammatori
cytokin
product
virusinfect
primari
felin
monocyt
macrophag
sever
diseas
report
exampl
equin
arter
viru
eav
virul
eav
significantli
induc
product
macrophag
compar
avirul
eav
similar
find
observ
equin
infecti
anemia
viru
therefor
may
correl
fcov
pathogenesi
level
inflammatori
cytokin
product
studi
ade
serotyp
fcov
infect
report
previous
report
serotyp
fipv
challeng
hasten
fip
develop
cat
carri
antiserotyp
fipv
antibodi
studi
ade
observ
serotyp
ii
cov
infect
also
serotyp
fcov
infect
howev
vitro
studi
mechan
ade
serotyp
fcov
infect
perform
mab
ade
activ
prepar
serotyp
fcov
prepar
antiserotyp
fcov
mab
ade
activ
similar
experi
use
anticip
confirm
ade
fipv
fecv
infect
also
confirm
differ
ade
fecv
fipv
infect
basic
analysi
ade
activ
fecv
lower
fipv
suggest
ade
activ
involv
differ
fcov
pathogen
necessari
close
analyz
ade
mechan
fecv
infect
use
cellular
imag
flow
cytometri
techniqu
furthermor
desir
investig
whether
differ
ade
activ
fecv
fipv
similar
observ
present
studi
fcreceptorexpress
cell
b
cell
neutrophil
monocyt
macrophag
hope
present
studi
help
understand
ade
fcov
infect
help
elucid
ade
serotyp
fcov
infect
